Founded in 2020, Steriscience is committed to advancing healthcare through state-of-the-art manufacturing capabilities, a robust development pipeline, and a growing global presence. We deliver reliable, innovative, and high-quality injectable therapies that address evolving healthcare needs and support better patient care.
Steriscience is committed to advancing patient care through the development and manufacturing of value-added sterile injectables that improve clinical workflows, reduce medication waste, and enhance efficiency in healthcare settings.
With a differentiated product portfolio, deep scientific expertise, and two state-of-the-art manufacturing facilities, we address critical challenges in the sterile injectables market, including supply reliability, sterility assurance, and technical complexity. By combining innovation, quality, and operational excellence, we are expanding global access to essential injectable therapies and helping healthcare providers deliver better patient outcomes.
Our facility is a trusted hub for sterile injectables, backed by an elite tier of global regulatory approvals
- Integrity
- Competency
- Efficiency
Our Values
Our objective is to achieve our desired goals by embracing a set of values that form the core of all our behaviour, actions, decisions, and processes. We live our values by demonstrating the highest levels of ethics to deliver our mission.
The three core values for Steriscience are:
30 Years of Heritage
Over 30 years of sterile manufacturing heritage a global partner of choice for critical hospital medications, combining deep market knowledge with a sophisticated manufacturing ecosystem.
Our Mission
We strive to improve patient care through innovative, value-added delivery formats that simplify complex treatments going beyond simple production to drive the future of sterile injectable care through expertise and innovation. We ensure every injectable we produce meets the highest standards of quality.
Leadership Team
Ankit Gupta
Chief Executive Officer
Swamy K N
Chief Technical Officer
Sangeetha K
Mohit Kumar
Head of Site Operations
Edyta Lipiec
Quality & Pharma Operations Head
Ashwin John
Director, Planning & Projects
Navigating Global Markets Through Strategic Partnerships
Since inception, SteriScience has developed 30+ products and completed 20+ regulatory filings, securing initial approvals in key markets, including the US, EU, and Canada.
We have established strategic partnerships with leading hospital-focused companies in the United States, strengthening our presence across anti-infectives, critical care, and value-added injectable therapies. Our existing business in Canada continues through select partnerships, supporting our global commercial footprint.
As we continue to expand our specialty and ready-to-use injectable portfolio, we are actively seeking partnerships across North America, Europe, Latin America, APAC, and MENA to broaden patient access to critical hospital medicines worldwide.
Our mission is to become a trusted global injectables partner, improving patient access and advancing healthcare outcomes worldwide.
In-Licensing & Out-Licensing Opportunities
Co-Development Partnerships
Contract Manufacturing (CMO) Services
Global Presence
An emerging, differentiated B2B injectable platform with extensive global reach.
- USA
- Africa
- India
- Australia